Windward Bio Group AG
WWB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002145089
In the last 90 days, Windward Bio Group AG insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysLast 90 days, $49.8M in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026
- 0
- 13F valueReported value at the end of Q3 2026
- $0
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Superinvestors holding WWB, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding WWB at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Windward Bio Group AG insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2026 (view filing)5:12 PM ET | Nov 16 | 2 days | Bonita David PDirector, 10% Owner | PPurchase | +1.18M | $17.00 | +$20.0M | +221.3%1.71M after | Duplicate filing |
| Nov 18, 2026 (view filing)5:08 PM ET | Nov 16 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +1.18M | $17.00 | +$20.0M | +221.3%1.71M after | |
| Nov 18, 2026 (view filing)4:30 PM ET | Nov 16 | 2 days | Stampacchia OtelloDirector | PPurchase | +1.75M | $17.00 | +$29.8M | New position875.0K after | 2 lots |
Top 10 13F holders, Q3 2026
View all: Top 10 13F holders, Q3 2026The largest institutional positions in Windward Bio Group AG at the end of Q3 2026; share changes are against Q2 2026.
No institution reported holding WWB in 13F filings for Q3 2026.